Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

166 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development and characterization of HPV-positive and HPV-negative head and neck squamous cell carcinoma tumorgrafts.
Kimple RJ, Harari PM, Torres AD, Yang RZ, Soriano BJ, Yu M, Armstrong EA, Blitzer GC, Smith MA, Lorenz LD, Lee D, Yang DT, McCulloch TM, Hartig GK, Lambert PF. Kimple RJ, et al. Among authors: yang rz, yang dt. Clin Cancer Res. 2013 Feb 15;19(4):855-64. doi: 10.1158/1078-0432.CCR-12-2746. Epub 2012 Dec 18. Clin Cancer Res. 2013. PMID: 23251001 Free PMC article.
Phase 1 trial of bevacizumab with concurrent chemoradiation therapy for squamous cell carcinoma of the head and neck with exploratory functional imaging of tumor hypoxia, proliferation, and perfusion.
Nyflot MJ, Kruser TJ, Traynor AM, Khuntia D, Yang DT, Hartig GK, McCulloch TM, Wiederholt PA, Gentry LR, Hoang T, Jeraj R, Harari PM. Nyflot MJ, et al. Among authors: yang dt. Int J Radiat Oncol Biol Phys. 2015 Apr 1;91(5):942-51. doi: 10.1016/j.ijrobp.2014.11.029. Epub 2015 Feb 3. Int J Radiat Oncol Biol Phys. 2015. PMID: 25659884 Free PMC article. Clinical Trial.
From Bench to Bedside: A Team's Approach to Multidisciplinary Strategies to Combat Therapeutic Resistance in Head and Neck Squamous Cell Carcinoma.
Crossman BE, Harmon RL, Kostecki KL, McDaniel NK, Iida M, Corday LW, Glitchev CE, Crow MT, Harris MA, Lin CY, Adams JM, Longhurst CA, Nickel KP, Ong IM, Alexandridis RA, Yu M, Yang DT, Hu R, Morris ZS, Hartig GK, Glazer TA, Ramisetty S, Kulkarni P, Salgia R, Kimple RJ, Bruce JY, Harari PM, Wheeler DL. Crossman BE, et al. Among authors: yang dt. J Clin Med. 2024 Oct 10;13(20):6036. doi: 10.3390/jcm13206036. J Clin Med. 2024. PMID: 39457986 Free PMC article. Review.
Vav1 in hematologic neoplasms, a mini review.
Oberley MJ, Wang DS, Yang DT. Oberley MJ, et al. Among authors: yang dt. Am J Blood Res. 2012;2(1):1-8. Epub 2012 Jan 1. Am J Blood Res. 2012. PMID: 22432082 Free PMC article.
Impact of initial chemotherapy regimen on outcomes for patients with double-expressor lymphoma: A multi-center analysis.
D'Angelo CR, Hanel W, Chen Y, Yu M, Yang D, Guo L, Karmali R, Burkart M, Ciccosanti C, David K, Risch Z, Murga-Zamalloa C, Devata S, Wilcox R, Savani M, Courville EL, Bachanova V, Rabinovich E, Peace D, Osman F, Epperla N, Kenkre VP. D'Angelo CR, et al. Hematol Oncol. 2021 Oct;39(4):473-482. doi: 10.1002/hon.2902. Epub 2021 Aug 4. Hematol Oncol. 2021. PMID: 34347909 Free PMC article.
166 results